Risedronate is well-tolerated in alendronate-intolerant postmenopausal women.

被引：0
|
作者：
Adachi, J
Adami, S
Miller, P
Olszynski, WP
Kendler, D
Silverman, S
Licata, A
Li, Z
Stevens, K
Long, PH
机构：
[1] Clin Valeggio, Valeggio, Italy
[2] Colorado Ctr Bone Res, Lakewood, CO USA
[3] Midtown Med Ctr, Saskatoon, SK, Canada
[4] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[5] Univ Calif Los Angeles, Los Angeles, CA USA
[6] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[7] Procter & Gamble Pharmaceut, Mason, OH USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2000年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SU401
引用
收藏
页码：S429 / S429
页数：1
相关论文
共 50 条
  • [1] Tolerability of risedronate in alendronate-intolerant postmenopausal women.
    Adachi, JD
    Adami, S
    Miller, PD
    Olszynski, WP
    Kendler, DL
    Silverman, SL
    Licata, A
    Li, Z
    Stevens, KP
    Horlait, S
    Long, PH
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S202 - S202
  • [2] Risedronate is well-tolerated in postmenopausal women who are GI-intolerant to alendronate
    Adami, S
    Adachi, JD
    Miller, PD
    Horlait, S
    [J]. BONE, 2001, 28 (05) : S228 - S228
  • [3] Risedronate is well-tolerated in women with postmenopausal osteoporosis
    Fogelman, I
    McClung, M
    Eastell, R
    Watts, N
    Hooper, M
    Ernst, T
    Bettica, P
    Reginster, JY
    [J]. OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S61 - S62
  • [4] Risedronate is well-tolerated in women with postmenopausal osteoporosis.
    McClung, M
    Eastell, R
    Watts, N
    Fogelman, I
    Hooper, M
    Ernst, T
    Bettica, P
    Reginster, JY
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S538 - S538
  • [5] Tolerability of risedronate in postmenopausal women intolerant of alendronate
    Adachi, JD
    Adami, S
    Miller, PD
    Olszynski, WP
    Kendler, DL
    Silverman, SL
    Licata, AA
    Li, Z
    Gomez-Panzani, E
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2001, 13 (05) : 347 - 354
  • [6] Tolerability of risedronate in postmenopausal women intolerant of alendronate
    J. D. Adachi
    S. Adami
    P. D. Miller
    W. P. Olszynski
    D. L. Kendler
    S. L. Silverman
    A. A. Licata
    Z. Li
    E. Gomez-Panzani
    [J]. Aging Clinical and Experimental Research, 2001, 13 : 347 - 354
  • [7] Endoscopy study comparing risedronate and alendronate in postmenopausal women.
    Lanza, FL
    Hunt, RH
    Thomson, AB
    Provenza, M
    Blank, MA
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A474 - A474
  • [8] Ibandronate is well tolerated by patients intolerant of weekly alendronate or risedronate: Results from the prior study
    Laster, A.
    Bonnick, S. L.
    Friend, K. E.
    Lewieke, E. M.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S136 - S136
  • [9] Risedronate increases bone mineral density and is well-tolerated in postmenopausal women with low bone mineral density.
    Ribot, C
    Smith, R
    Fogelman, I
    Bettica, P
    Pack, S
    Ethgen, D
    Reginster, JY
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S136 - S136
  • [10] Prior study: ibandronate is preferred and tolerated in patients intolerant of alendronate or risedronate
    Lewiecki, E. M.
    Bonnick, S. L.
    Friend, K.
    Laster, A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S125 - S126
12345